Verint Systems Inc (NASDAQ: VRNT) has reported E.P.S. of $0.12 for its third fiscal quarter (ending October 31) versus $-0.02 for the same period a year ago. For the latest four quarters through October 31, […]
On 12/6/23, TG Therapeutics Inc (NASDAQ: TGTX) stock enjoyed a major increase of 14.9%, closing at $16.45. Moreover, this advance was accompanied by above average trading volume at 145% of normal. Relative to the market […]
Campbell Soup Co (NYSE: CPB) has reported E.P.S. of $0.79 for its first fiscal quarter (ending October 31) versus $0.99 for the same period a year ago — a decline of -20%. This performance was […]
Recent extremely meaningful positive changes in investment behavior have benefitted National Bankshares Inc (NASDAQ: NKSH): positive upside/downside volume developed, its shorter term price trend turned up, and the stock rose on very heavy volume. Recent […]
Extremely important positive changes in investment behavior have recently occurred for Anixa Biosciences Inc (NASDAQ: ANIX): its shorter term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, positive upside/downside […]
Recent meaningful negative changes in investment behavior have impacted Harvard Bioscience Inc (NASDAQ: HBIO): the stock’s recent price decline challenged its longer term uptrend. Harvard Bioscience Inc (NASDAQ: HBIO) has recently experienced extremely important negative […]
Recent meaningful negative changes in investment behavior have impacted Harmonic Inc (NASDAQ: HLIT): the stock fell on very heavy volume. Harmonic Inc (NASDAQ: HLIT) has recently experienced significant negative changes in fundamentals: the consensus estimate […]
Travere Therapeutics Inc (NASDAQ: TVTX) stock enjoyed a major increase of 17.6% on 12/5/23. The shares closed at $7.40. Moreover, this advance was accompanied by exceptionally high trading volume at 386% of normal. The stock […]
On 12/5/23, Merit Medical Systems Inc (NASDAQ: MMSI) stock suffered a major decline of -11.4%, closing at $65.53. Moreover, trading volume in this decline was exceptionally high at 797% of normal. The stock has performed […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Harrow Health Inc (NASDAQ: HROW) fell significantly of late. HROW’s current Value Trend Rating is F and the prior Rating […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research